(Q33226719)

24 July 2017

title

Anti-hepatoma effect of arsenic trioxide on experimental liver cancer induced by 2-acetamidofluorene in rats (English)

1 reference

24 July 2017

0 references

1 reference

Bing Tan

1

1 reference

24 July 2017

Jie-Fei Huang

2

1 reference

24 July 2017

Qun Wei

3

1 reference

24 July 2017

Hong Zhang

4

1 reference

24 July 2017

Run-Zhou Ni

5

1 reference

24 July 2017

language of work or name

English

0 references

publication date

1 October 2005

1 reference

World Journal of Gastroenterology

24 July 2017

published in

1 reference

24 July 2017

volume

11

1 reference

24 July 2017

issue

38

1 reference

24 July 2017

page(s)

5938-5943

1 reference

Establishment and characterization of four human hepatocellular carcinoma cell lines containing hepatitis B virus DNA

24 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436714

The alteration of mitochondria is an early event of arsenic trioxide induced apoptosis in esophageal carcinoma cells

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436714

Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436714

Gene therapy strategies for tumor antiangiogenesis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436714

In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436714

Phase II study of flutamide in the treatment of hepatocellular carcinoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436714

Treatment of hepatocellular carcinoma with combined suppression and inhibition of sex hormones: a randomized, controlled trial

21 June 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16273603

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Microvessel density, vascular endothelial growth factor and its receptors Flt-1 and Flk-1/KDR in hepatocellular carcinoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16273603

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3748/WJG.V11.I38.5938

1 reference

24 July 2017

1 reference

24 July 2017

1 reference